Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative; Data from 10,000 individuals affected by SARS-CoV-2 will be used to identify biomarkers that can help predict potential risk of serious disease and support the development of nov

  • Michael Smith

Press/Media

Period3 Nov 2021

Media coverage

1

Media coverage

  • TitleIllumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative; Data from 10,000 individuals affected by SARS-CoV-2 will be used to identify biomarkers that can help predict potential risk of serious disease and support the development of nov
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date3/11/21
    PersonsMichael Smith